SEOM-GG clinical guidelines for the management of germ-cell testicular cancer (2023).

Autor: Arranz Arija JA; Hospital General Universitario Gregorio Marañón, Madrid, Spain. jarranza.oncomed@gmail.com., Del Muro XG; Hospital Duran I Reynals, Institut Català D'Oncologia L'Hospitalet (ICO), Barcelona, Spain., Caro RL; Hospital Universitario Virgen de Las Nieves, Instituto de Investigación Biosanitaria Ibs, Granada, Spain., Méndez-Vidal MJ; Hospital Universitario Reina Sofía, Córdoba, Spain., Pérez-Valderrama B; Hospital Universitario Virgen del Rocío, Seville, Spain., Aparicio J; Hospital Universitario I Politècnic La Fe, Valencia, Spain., Climent Durán MÁ; Instituto Valenciano de Oncología, Valencia, Spain., Caballero Díaz C; Consorcio Hospital General Universitario de Valencia, Valencia, Spain., Durán I; Hospital Universitario Marqués de Valdecilla, Santander, Spain., González-Billalabeitia E; Hospital Universitario 12 de Octubre, IMAS 12, UCAM, Madrid, Spain.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Nov; Vol. 26 (11), pp. 2783-2799. Date of Electronic Publication: 2024 Jul 03.

Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial.

Autor: Climent MÁ; Valencian Institute of Oncology, Valencia, Spain., Álvarez C; Hospital Universitario Central de Asturias, Oviedo, Spain., Morales R; Vall d'Hebron University Hospital, Barcelona, Spain., Maroto P; Hospital Universitari de La Santa Creu I Sant Pau, Barcelona, Spain., Rodríguez-Vida A; Hospital del Mar-CIBERONC, IMIM Research Institute, Barcelona, Spain., Méndez-Vidal MJ; Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Reina Sofia University Hospital (HURS), Cordoba, Spain., Del Muro XG; Catalan Institute of Oncology, Barcelona, Spain., Puente J; Hospital Universitario Clínico San Carlos, Madrid, Spain., Láinez N; University Hospital of Navarra, Pamplona, Spain., Vázquez S; Hospital Universitario Lucus Augusti, Lugo, Spain., Castellano D; Hospital 12 de Octubre, Madrid, Spain., Lang CG; Merck S.L.U., an Affiliate of Merck KGaA, Madrid, Spain., Wang J; Pfizer, Cambridge, MA, USA., di Pietro A; Pfizer Srl, Milan, Italy., Davis C; Pfizer Translational Oncology, La Jolla, CA, USA., Sanz-Castillo B; Pfizer Oncology, Madrid, Spain., Bolós MV; Pfizer Oncology, Madrid, Spain., Valderrama BP; Virgen del Rocío University Hospital, Seville, Spain. bpvalderrama@gmail.com.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jun; Vol. 26 (6), pp. 1532-1538. Date of Electronic Publication: 2023 Dec 15.

Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer

Autor: Maroto, P, del Muro, XG, Valverde, C, Pinto, A, Sanchez, A, Guma, J, Alonso, T, del Prado, PM, Vazquez, S, Mellado, B, Aparicio, J, Fernandez-Aramburo, A, Girones, R, Terrasa, J, Spanish Germ Cell Canc Grp

Publikováno v: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

Background: Incidence of a second testicular tumor is higher in patients diagnosed with testicular cancer than in the general population. As incidence of unilateral germ cell cancer is increasing worldwide and most of these patients are cured, a grow

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::00595d2a730b916f39e04abd51be8542
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7790

Prognostic significance of docetaxel (D) plus androgen-deprivation therapy (ADT) in patients (p) with metastatic castration-sensitive prostate cancer (mCSPC) according to extent of disease: A study of real-world data

Autor: Notario, L, Piulats, JM, Sala, N, Ferrandiz, U, Gonzalez, A, Etxaniz, O, Villa, S, Buisan, O, Boladeras, A, Heras, L, Del Carpio, L, Rosello, A, Barretina, P, Fina, C, Pardo, JC, Suarez, JM, Comet, J, del Muro, XG, Esteve, A, Font, A

Publikováno v: Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::171feb440306b68225ac40b34aa46a99
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3995

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Autor: Casali PG; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Oncology and Hemato-oncology University of Milan, Milan, Italy., Blay JY; Centre Leon Berard and UCBL1, Lyon, France., Abecassis N; Instituto Portugues de Oncologia de Lisboa Francisco Gentil, EPE, Lisbon, Portugal., Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Bauer S; Department of Medical Oncology, Interdisciplinary Sarcoma Center, West German Cancer Center, University of Duisburg-Essen, Essen, Germany., Biagini R; Department of Oncological Orthopedics, Musculoskeletal Tissue Bank, IFO, Regina Elena National Cancer Institute, Rome, Italy., Bielack S; Klinikum Stuttgart-Olgahospital, Stuttgart, Germany., Bonvalot S; Department of Surgery, Institut Curie, Paris, France., Boukovinas I; Bioclinic Thessaloniki, Thessaloniki, Greece., Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Boye K; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Brodowicz T; Vienna General Hospital (AKH), Medizinische Universität Wien, Vienna, Austria., Buonadonna A; Centro di Riferimento Oncologico di Aviano, Aviano, Italy., De Álava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain; Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain., Dei Tos AP; Department of Pathology, Azienda Ospedale Università Padova, Padova, Italy., Del Muro XG; Integrated Unit ICO Hospitalet, HUB, Barcelona, Spain., Dufresne A; Département d'Oncologie Médicale, Centre Leon Berard, Lyon, France., Eriksson M; Skane University Hospital-Lund, Lund, Sweden., Fedenko A; P. A. Herzen Cancer Research Institute, Moscow, Russian Federation., Ferraresi V; Sarcomas and Rare Tumors Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ferrari A; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Frezza AM; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Gasperoni S; Department of Oncology and Robotic Surgery, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Gouin F; Centre Leon-Berard Lyon, Lyon, France., Grignani G; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy., Haas R; Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiotherapy, Leiden University Medical Centre, Leiden, The Netherlands., Hassan AB; Oxford University Hospitals NHS Foundation Trust and University of Oxford, Oxford, UK., Hindi N; Department of Medical Oncology, Fundación Jimenez Diaz, University Hospital, Advanced Therapies in Sarcoma Lab, Madrid, Spain., Hohenberger P; Mannheim University Medical Center, Mannheim, Germany., Joensuu H; Helsinki University Hospital (HUH) and University of Helsinki, Helsinki, Finland., Jones RL; Sarcoma Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Jungels C; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Jutte P; University Medical Center Groningen, Groningen, The Netherlands., Kasper B; Mannheim University Medical Center, Mannheim, Germany., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Kopeckova K; University Hospital Motol, Prague, Czech Republic., Krákorová DA; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Le Cesne A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Le Grange F; Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH), London, UK., Legius E; Department for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Leithner A; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria., Lopez-Pousa A; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain., Martin-Broto J; Department of Medical Oncology, Fundación Jimenez Diaz, University Hospital, Advanced Therapies in Sarcoma Lab, Madrid, Spain., Merimsky O; Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel., Messiou C; Department of Radiology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Miah AB; Department of Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Mir O; Department of Ambulatory Cancer Care, Gustave Roussy, Villejuif, France., Montemurro M; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Morosi C; Department of Radiology, IRCCS Foundation National Cancer Institute, Milan, Italy., Palmerini E; Department of Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Pantaleo MA; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria, di Bologna, Bologna, Italy., Piana R; Azienda Ospedaliero, Universitaria Città della Salute e della Scienza di Torino, Turin, Italy., Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France., Reichardt P; Helios Klinikum Berlin Buch, Berlin, Germany., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Safwat AA; Aarhus University Hospital, Aarhus, Denmark., Sangalli C; Department of Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sbaraglia M; Department of Pathology, Azienda Ospedale Università Padova, Padova, Italy., Scheipl S; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria., Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Strauss D; Department of Surgery, Royal Marsden Hospital, London, UK., Strauss SJ; Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH), London, UK., Hall KS; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Trama A; Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Unk M; Institute of Oncology of Ljubljana, Ljubljana, Slovenia., van de Sande MAJ; Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands., van Houdt WJ; Department of Surgical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands., Frebourg T; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy., Stacchiotti S; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Jan; Vol. 33 (1), pp. 20-33. Date of Electronic Publication: 2021 Sep 21.